Arlington Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30K Buy
136
+28
+26% +$7.75K ﹤0.01% 340
2026
Q1
$31.9K Buy
108
+52
+93% +$15.4K ﹤0.01% 274
2025
Q4
$15.3K Sell
56
-491
-90% -$133K ﹤0.01% 274
2025
Q3
$148K Hold
547
0.03% 219
2025
Q2
$151K Hold
547
0.03% 204
2025
Q1
$145K Hold
547
0.03% 210
2024
Q4
$127K Hold
547
0.03% 233
2024
Q3
$121K Buy
547
+27
+5% +$5.59K 0.03% 232
2024
Q2
$102K Hold
520
0.02% 253
2024
Q1
$112K Sell
520
-20
-4% -$4.2K 0.03% 205
2023
Q4
$114K Buy
+540
New +$115K 0.03% 206

Other funds holding CME

Arlington Trust's CME Position: Q2 2026 in Review

Arlington Trust increased its CME Group (CME) stake by 26% in Q2 2026, buying an estimated $7.75K and bringing the position to 136 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Arlington Trust first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $151K in Q2 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Arlington Trust held 136 shares of CME Group worth $30K as of Q2 2026.
  • Arlington Trust bought 28 CME Group shares in Q2 2026, an estimated $7.75K.
  • CME Group made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #340 holding.
  • Arlington Trust first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Arlington Trust's CME Group position peaked at $151K in Q2 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.